StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.78−1.10 (-5.03%)

Close on Nov 17, 2026Market cap $1.44BP/E –Yield –

uniQure profit margin

Profit margin (net margin) is net income as a percentage of revenue.

uniQure's profit margin for the twelve months ending Jun 30, 2026 was -1350.7%. For fiscal 2025 it was -1236.0%, against -883.4% the year before.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1236.0%−352.6
FY2024Dec 31, 2024-883.4%+1063.7
FY2023Dec 31, 2023-1947.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-1387.8%−670.9
Q1 FY2026Mar 31, 2026-1502.9%+1281.8
Q4 FY2025Dec 31, 2025-666.1%+737.1
Q3 FY2025Sep 30, 2025-2175.9%−235.4
Q2 FY2025Jun 30, 2025-716.8%−210.8
Q1 FY2025Mar 31, 2025-2784.7%–
Q4 FY2024Dec 31, 2024-1403.2%–
Q3 FY2024Sep 30, 2024-1940.4%–
Q2 FY2024Jun 30, 2024-506.0%–

More uniQure figures

See a number that looks wrong?